- Preview Available
- Scholarly Journal
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
Negrier, Sylvie; Perol, David; Bahleda, Rastislav; Hollebecque, Antoine; Chatelut, Etienne
; et al.
BMC Cancer; London Vol. 17, (2017).
DOI:10.1186/s12885-017-3527-7
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.